+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Relapsed Acute Myeloid Leukemia Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • PDF Icon

    Report

  • 97 Pages
  • July 2024
  • Region: Global
  • Prof Research
  • ID: 5940888
Description Jump to:

Quick Summary:

In the dynamic landscape of pharmaceuticals, the Relapsed Acute Myeloid Leukemia (AML) drug market stands out with relentless advancements and significant investments. Executives seeking to optimize their strategic positioning should grasp the intricate market interplay, a task that this comprehensive report renders straightforward.

Structured to provide an in-depth analysis of trends, our report offers key insights into regional markets, detailing supply and demand dynamics, pivotal players, and pricing structures across North America to MEA. The granularity of data includes essential countries, ensuring a thorough understanding of local nuances that drive the global AML drug industry.

Armed with the knowledge from a SWOT analysis of mainstay and emergent competitors, leaders can benchmark performance and guide informed decision-making. This report becomes an indispensable tool for those looking to master the commercial landscape of AML treatment, offering guidance for clinics, hospitals, and beyond. With profiles of leading companies and an outlook until the end of the decade, this report is your strategic companion in navigating the complexities of the Relapsed AML drug market.

This report describes the global market size of Relapsed Acute Myeloid Leukemia Drug from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Relapsed Acute Myeloid Leukemia Drug as well as some smaller players.

The information for each competitor includes:

  • Company Profile
  • Main Business Information
  • SWOT Analysis
  • Sales Volume, Revenue, Price and Gross Margin
  • Market Share

Applications Segment:

  • Clinic
  • Hospital
  • Others

Companies Covered:

  • 4SC AG
  • AbbVie Inc.
  • Actinium Pharmaceuticals Inc.
  • Agios Pharmaceuticals Inc.
  • Amgen Inc.
  • Arog Pharmaceuticals Inc.
  • Array BioPharma Inc.
  • Astellas Pharma Inc.
  • Astex Pharmaceuticals Inc.
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Relapsed Acute Myeloid Leukemia Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Trading Analysis
8.1 Export of Relapsed Acute Myeloid Leukemia Drug by Region
8.2 Import of Relapsed Acute Myeloid Leukemia Drug by Region
8.3 Balance of Trade
Chapter 9 Historical and Forecast Relapsed Acute Myeloid Leukemia Drug Market in North America (2019-2029)
9.1 Relapsed Acute Myeloid Leukemia Drug Market Size
9.2 Relapsed Acute Myeloid Leukemia Drug Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis
9.5.1 United States
9.5.2 Canada
9.5.3 Mexico
Chapter 10 Historical and Forecast Relapsed Acute Myeloid Leukemia Drug Market in South America (2019-2029)
10.1 Relapsed Acute Myeloid Leukemia Drug Market Size
10.2 Relapsed Acute Myeloid Leukemia Drug Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Chile
10.5.4 Peru
Chapter 11 Historical and Forecast Relapsed Acute Myeloid Leukemia Drug Market in Asia & Pacific (2019-2029)
11.1 Relapsed Acute Myeloid Leukemia Drug Market Size
11.2 Relapsed Acute Myeloid Leukemia Drug Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis
11.5.1 China
11.5.2 India
11.5.3 Japan
11.5.4 South Korea
11.5.5 Southeast Asia
11.5.6 Australia
Chapter 12 Historical and Forecast Relapsed Acute Myeloid Leukemia Drug Market in Europe (2019-2029)
12.1 Relapsed Acute Myeloid Leukemia Drug Market Size
12.2 Relapsed Acute Myeloid Leukemia Drug Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis
12.5.1 Germany
12.5.2 France
12.5.3 United Kingdom
12.5.4 Italy
12.5.5 Spain
12.5.6 Belgium
12.5.7 Netherlands
12.5.8 Austria
12.5.9 Poland
12.5.10 Russia
Chapter 13 Historical and Forecast Relapsed Acute Myeloid Leukemia Drug Market in MEA (2019-2029)
13.1 Relapsed Acute Myeloid Leukemia Drug Market Size
13.2 Relapsed Acute Myeloid Leukemia Drug Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis
13.5.1 Egypt
13.5.2 Israel
13.5.3 South Africa
13.5.4 Gulf Cooperation Council Countries
13.5.5 Turkey
Chapter 14 Summary For Global Relapsed Acute Myeloid Leukemia Drug Market (2019-2024)
14.1 Relapsed Acute Myeloid Leukemia Drug Market Size
14.2 Relapsed Acute Myeloid Leukemia Drug Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price
Chapter 15 Global Relapsed Acute Myeloid Leukemia Drug Market Forecast (2024-2029)
15.1 Relapsed Acute Myeloid Leukemia Drug Market Size Forecast
15.2 Relapsed Acute Myeloid Leukemia Drug Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast
Chapter 16 Analysis of Global Key Vendors
16.1 4SC AG
16.1.1 Company Profile
16.1.2 Main Business and Relapsed Acute Myeloid Leukemia Drug Information
16.1.3 SWOT Analysis of 4SC AG
16.1.4 4SC AG Relapsed Acute Myeloid Leukemia Drug Sales, Revenue, Price and Gross Margin (2019-2024)
16.2 AbbVie Inc.
16.2.1 Company Profile
16.2.2 Main Business and Relapsed Acute Myeloid Leukemia Drug Information
16.2.3 SWOT Analysis of AbbVie Inc.
16.2.4 AbbVie Inc. Relapsed Acute Myeloid Leukemia Drug Sales, Revenue, Price and Gross Margin (2019-2024)
16.3 Actinium Pharmaceuticals Inc.
16.3.1 Company Profile
16.3.2 Main Business and Relapsed Acute Myeloid Leukemia Drug Information
16.3.3 SWOT Analysis of Actinium Pharmaceuticals Inc.
16.3.4 Actinium Pharmaceuticals Inc. Relapsed Acute Myeloid Leukemia Drug Sales, Revenue, Price and Gross Margin (2019-2024)
16.4 Agios Pharmaceuticals Inc.
16.4.1 Company Profile
16.4.2 Main Business and Relapsed Acute Myeloid Leukemia Drug Information
16.4.3 SWOT Analysis of Agios Pharmaceuticals Inc.
16.4.4 Agios Pharmaceuticals Inc. Relapsed Acute Myeloid Leukemia Drug Sales, Revenue, Price and Gross Margin (2019-2024)
16.5 Amgen Inc.
16.5.1 Company Profile
16.5.2 Main Business and Relapsed Acute Myeloid Leukemia Drug Information
16.5.3 SWOT Analysis of Amgen Inc.
16.5.4 Amgen Inc. Relapsed Acute Myeloid Leukemia Drug Sales, Revenue, Price and Gross Margin (2019-2024)
16.6 Arog Pharmaceuticals Inc.
16.6.1 Company Profile
16.6.2 Main Business and Relapsed Acute Myeloid Leukemia Drug Information
16.6.3 SWOT Analysis of Arog Pharmaceuticals Inc.
16.6.4 Arog Pharmaceuticals Inc. Relapsed Acute Myeloid Leukemia Drug Sales, Revenue, Price and Gross Margin (2019-2024)
16.7 Array BioPharma Inc.
16.7.1 Company Profile
16.7.2 Main Business and Relapsed Acute Myeloid Leukemia Drug Information
16.7.3 SWOT Analysis of Array BioPharma Inc.
16.7.4 Array BioPharma Inc. Relapsed Acute Myeloid Leukemia Drug Sales, Revenue, Price and Gross Margin (2019-2024)
16.8 Astellas Pharma Inc.
16.8.1 Company Profile
16.8.2 Main Business and Relapsed Acute Myeloid Leukemia Drug Information
16.8.3 SWOT Analysis of Astellas Pharma Inc.
16.8.4 Astellas Pharma Inc. Relapsed Acute Myeloid Leukemia Drug Sales, Revenue, Price and Gross Margin (2019-2024)
16.9 Astex Pharmaceuticals Inc.
16.9.1 Company Profile
16.9.2 Main Business and Relapsed Acute Myeloid Leukemia Drug Information
16.9.3 SWOT Analysis of Astex Pharmaceuticals Inc.
16.9.4 Astex Pharmaceuticals Inc. Relapsed Acute Myeloid Leukemia Drug Sales, Revenue, Price and Gross Margin (2019-2024)
Tables and Figures
Table Abbreviation and Acronyms List
Table Research Scope of Relapsed Acute Myeloid Leukemia Drug Report
Table Data Sources of Relapsed Acute Myeloid Leukemia Drug Report
Table Major Assumptions of Relapsed Acute Myeloid Leukemia Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Relapsed Acute Myeloid Leukemia Drug Picture
Table Relapsed Acute Myeloid Leukemia Drug Classification
Table Relapsed Acute Myeloid Leukemia Drug Applications List
Table Drivers of Relapsed Acute Myeloid Leukemia Drug Market
Table Restraints of Relapsed Acute Myeloid Leukemia Drug Market
Table Opportunities of Relapsed Acute Myeloid Leukemia Drug Market
Table Threats of Relapsed Acute Myeloid Leukemia Drug Market
Table COVID-19 Impact For Relapsed Acute Myeloid Leukemia Drug Market
Table Raw Materials Suppliers List
Table Different Production Methods of Relapsed Acute Myeloid Leukemia Drug
Table Cost Structure Analysis of Relapsed Acute Myeloid Leukemia Drug
Table Key End Users List
Table Latest News of Relapsed Acute Myeloid Leukemia Drug Market
Table Merger and Acquisition List
Table Planned/Future Project of Relapsed Acute Myeloid Leukemia Drug Market
Table Policy of Relapsed Acute Myeloid Leukemia Drug Market
Table 2019-2029 Regional Export of Relapsed Acute Myeloid Leukemia Drug
Table 2019-2029 Regional Import of Relapsed Acute Myeloid Leukemia Drug
Table 2019-2029 Regional Trade Balance
Figure 2019-2029 Regional Trade Balance
Table 2019-2029 North America Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Figure 2019-2029 North America Relapsed Acute Myeloid Leukemia Drug Market Size and CAGR
Figure 2019-2029 North America Relapsed Acute Myeloid Leukemia Drug Market Volume and CAGR
Table 2019-2029 North America Relapsed Acute Myeloid Leukemia Drug Demand List by Application
Table 2019-2024 North America Relapsed Acute Myeloid Leukemia Drug Key Players Sales List
Table 2019-2024 North America Relapsed Acute Myeloid Leukemia Drug Key Players Market Share List
Table 2019-2029 North America Relapsed Acute Myeloid Leukemia Drug Demand List by Type
Table 2019-2024 North America Relapsed Acute Myeloid Leukemia Drug Price List by Type
Table 2019-2029 United States Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 United States Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 Canada Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 Canada Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 Mexico Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 Mexico Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 South America Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Figure 2019-2029 South America Relapsed Acute Myeloid Leukemia Drug Market Size and CAGR
Figure 2019-2029 South America Relapsed Acute Myeloid Leukemia Drug Market Volume and CAGR
Table 2019-2029 South America Relapsed Acute Myeloid Leukemia Drug Demand List by Application
Table 2019-2024 South America Relapsed Acute Myeloid Leukemia Drug Key Players Sales List
Table 2019-2024 South America Relapsed Acute Myeloid Leukemia Drug Key Players Market Share List
Table 2019-2029 South America Relapsed Acute Myeloid Leukemia Drug Demand List by Type
Table 2019-2024 South America Relapsed Acute Myeloid Leukemia Drug Price List by Type
Table 2019-2029 Brazil Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 Brazil Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 Argentina Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 Argentina Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 Chile Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 Chile Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 Peru Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 Peru Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 Asia & Pacific Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Figure 2019-2029 Asia & Pacific Relapsed Acute Myeloid Leukemia Drug Market Size and CAGR
Figure 2019-2029 Asia & Pacific Relapsed Acute Myeloid Leukemia Drug Market Volume and CAGR
Table 2019-2029 Asia & Pacific Relapsed Acute Myeloid Leukemia Drug Demand List by Application
Table 2019-2024 Asia & Pacific Relapsed Acute Myeloid Leukemia Drug Key Players Sales List
Table 2019-2024 Asia & Pacific Relapsed Acute Myeloid Leukemia Drug Key Players Market Share List
Table 2019-2029 Asia & Pacific Relapsed Acute Myeloid Leukemia Drug Demand List by Type
Table 2019-2024 Asia & Pacific Relapsed Acute Myeloid Leukemia Drug Price List by Type
Table 2019-2029 China Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 China Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 India Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 India Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 Japan Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 Japan Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 South Korea Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 South Korea Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 Southeast Asia Relapsed Acute Myeloid Leukemia Drug Market Size List
Table 2019-2029 Southeast Asia Relapsed Acute Myeloid Leukemia Drug Market Volume List
Table 2019-2029 Southeast Asia Relapsed Acute Myeloid Leukemia Drug Import List
Table 2019-2029 Southeast Asia Relapsed Acute Myeloid Leukemia Drug Export List
Table 2019-2029 Australia Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 Australia Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 Europe Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Figure 2019-2029 Europe Relapsed Acute Myeloid Leukemia Drug Market Size and CAGR
Figure 2019-2029 Europe Relapsed Acute Myeloid Leukemia Drug Market Volume and CAGR
Table 2019-2029 Europe Relapsed Acute Myeloid Leukemia Drug Demand List by Application
Table 2019-2024 Europe Relapsed Acute Myeloid Leukemia Drug Key Players Sales List
Table 2019-2024 Europe Relapsed Acute Myeloid Leukemia Drug Key Players Market Share List
Table 2019-2029 Europe Relapsed Acute Myeloid Leukemia Drug Demand List by Type
Table 2019-2024 Europe Relapsed Acute Myeloid Leukemia Drug Price List by Type
Table 2019-2029 Germany Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 Germany Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 France Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 France Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 United Kingdom Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 United Kingdom Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 Italy Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 Italy Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 Spain Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 Spain Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 Belgium Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 Belgium Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 Netherlands Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 Netherlands Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 Austria Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 Austria Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 Poland Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 Poland Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 Russia Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 Russia Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 MEA Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Figure 2019-2029 MEA Relapsed Acute Myeloid Leukemia Drug Market Size and CAGR
Figure 2019-2029 MEA Relapsed Acute Myeloid Leukemia Drug Market Volume and CAGR
Table 2019-2029 MEA Relapsed Acute Myeloid Leukemia Drug Demand List by Application
Table 2019-2024 MEA Relapsed Acute Myeloid Leukemia Drug Key Players Sales List
Table 2019-2024 MEA Relapsed Acute Myeloid Leukemia Drug Key Players Market Share List
Table 2019-2029 MEA Relapsed Acute Myeloid Leukemia Drug Demand List by Type
Table 2019-2024 MEA Relapsed Acute Myeloid Leukemia Drug Price List by Type
Table 2019-2029 Egypt Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 Egypt Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 Israel Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 Israel Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 South Africa Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 South Africa Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 Gulf Cooperation Council Countries Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 Gulf Cooperation Council Countries Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2029 Turkey Relapsed Acute Myeloid Leukemia Drug Market Size and Market Volume List
Table 2019-2029 Turkey Relapsed Acute Myeloid Leukemia Drug Import & Export List
Table 2019-2024 Global Relapsed Acute Myeloid Leukemia Drug Market Size List by Region
Table 2019-2024 Global Relapsed Acute Myeloid Leukemia Drug Market Size Share List by Region
Table 2019-2024 Global Relapsed Acute Myeloid Leukemia Drug Market Volume List by Region
Table 2019-2024 Global Relapsed Acute Myeloid Leukemia Drug Market Volume Share List by Region
Table 2019-2024 Global Relapsed Acute Myeloid Leukemia Drug Demand List by Application
Table 2019-2024 Global Relapsed Acute Myeloid Leukemia Drug Demand Market Share List by Application
Table 2019-2024 Global Relapsed Acute Myeloid Leukemia Drug Key Vendors Sales List
Table 2019-2024 Global Relapsed Acute Myeloid Leukemia Drug Key Vendors Sales Share List
Figure 2019-2024 Global Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
Table 2019-2024 Global Relapsed Acute Myeloid Leukemia Drug Key Vendors Revenue List
Figure 2019-2024 Global Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate
Table 2019-2024 Global Relapsed Acute Myeloid Leukemia Drug Key Vendors Revenue Share List
Table 2019-2024 Global Relapsed Acute Myeloid Leukemia Drug Demand List by Type
Table 2019-2024 Global Relapsed Acute Myeloid Leukemia Drug Demand Market Share List by Type
Table 2019-2024 Regional Relapsed Acute Myeloid Leukemia Drug Price List
Table 2024-2029 Global Relapsed Acute Myeloid Leukemia Drug Market Size List by Region
Table 2024-2029 Global Relapsed Acute Myeloid Leukemia Drug Market Size Share List by Region
Table 2024-2029 Global Relapsed Acute Myeloid Leukemia Drug Market Volume List by Region
Table 2024-2029 Global Relapsed Acute Myeloid Leukemia Drug Market Volume Share List by Region
Table 2024-2029 Global Relapsed Acute Myeloid Leukemia Drug Demand List by Application
Table 2024-2029 Global Relapsed Acute Myeloid Leukemia Drug Demand Market Share List by Application
Table 2024-2029 Global Relapsed Acute Myeloid Leukemia Drug Key Vendors Sales List
Table 2024-2029 Global Relapsed Acute Myeloid Leukemia Drug Key Vendors Sales Share List
Figure 2024-2029 Global Relapsed Acute Myeloid Leukemia Drug Market Volume and Growth Rate
Table 2024-2029 Global Relapsed Acute Myeloid Leukemia Drug Key Vendors Revenue List
Figure 2024-2029 Global Relapsed Acute Myeloid Leukemia Drug Market Size and Growth Rate
Table 2024-2029 Global Relapsed Acute Myeloid Leukemia Drug Key Vendors Revenue Share List
Table 2024-2029 Global Relapsed Acute Myeloid Leukemia Drug Demand List by Type
Table 2024-2029 Global Relapsed Acute Myeloid Leukemia Drug Demand Market Share List by Type
Table 2024-2029 Relapsed Acute Myeloid Leukemia Drug Regional Price List
Table 4SC AG Information
Table SWOT Analysis of 4SC AG
Table 2019-2024 4SC AG Relapsed Acute Myeloid Leukemia Drug Sale Volume Price Cost Revenue
Figure 2019-2024 4SC AG Relapsed Acute Myeloid Leukemia Drug Sale Volume and Growth Rate
Figure 2019-2024 4SC AG Relapsed Acute Myeloid Leukemia Drug Market Share
Table AbbVie Inc. Information
Table SWOT Analysis of AbbVie Inc.
Table 2019-2024 AbbVie Inc. Relapsed Acute Myeloid Leukemia Drug Sale Volume Price Cost Revenue
Figure 2019-2024 AbbVie Inc. Relapsed Acute Myeloid Leukemia Drug Sale Volume and Growth Rate
Figure 2019-2024 AbbVie Inc. Relapsed Acute Myeloid Leukemia Drug Market Share
Table Actinium Pharmaceuticals Inc. Information
Table SWOT Analysis of Actinium Pharmaceuticals Inc.
Table 2019-2024 Actinium Pharmaceuticals Inc. Relapsed Acute Myeloid Leukemia Drug Sale Volume Price Cost Revenue
Figure 2019-2024 Actinium Pharmaceuticals Inc. Relapsed Acute Myeloid Leukemia Drug Sale Volume and Growth Rate
Figure 2019-2024 Actinium Pharmaceuticals Inc. Relapsed Acute Myeloid Leukemia Drug Market Share
Table Agios Pharmaceuticals Inc. Information
Table SWOT Analysis of Agios Pharmaceuticals Inc.
Table 2019-2024 Agios Pharmaceuticals Inc. Relapsed Acute Myeloid Leukemia Drug Sale Volume Price Cost Revenue
Figure 2019-2024 Agios Pharmaceuticals Inc. Relapsed Acute Myeloid Leukemia Drug Sale Volume and Growth Rate
Figure 2019-2024 Agios Pharmaceuticals Inc. Relapsed Acute Myeloid Leukemia Drug Market Share
Table Amgen Inc. Information
Table SWOT Analysis of Amgen Inc.
Table 2019-2024 Amgen Inc. Relapsed Acute Myeloid Leukemia Drug Sale Volume Price Cost Revenue
Figure 2019-2024 Amgen Inc. Relapsed Acute Myeloid Leukemia Drug Sale Volume and Growth Rate
Figure 2019-2024 Amgen Inc. Relapsed Acute Myeloid Leukemia Drug Market Share
Table Arog Pharmaceuticals Inc. Information
Table SWOT Analysis of Arog Pharmaceuticals Inc.
Table 2019-2024 Arog Pharmaceuticals Inc. Relapsed Acute Myeloid Leukemia Drug Sale Volume Price Cost Revenue
Figure 2019-2024 Arog Pharmaceuticals Inc. Relapsed Acute Myeloid Leukemia Drug Sale Volume and Growth Rate
Figure 2019-2024 Arog Pharmaceuticals Inc. Relapsed Acute Myeloid Leukemia Drug Market Share
Table Array BioPharma Inc. Information
Table SWOT Analysis of Array BioPharma Inc.
Table 2019-2024 Array BioPharma Inc. Relapsed Acute Myeloid Leukemia Drug Sale Volume Price Cost Revenue
Figure 2019-2024 Array BioPharma Inc. Relapsed Acute Myeloid Leukemia Drug Sale Volume and Growth Rate
Figure 2019-2024 Array BioPharma Inc. Relapsed Acute Myeloid Leukemia Drug Market Share
Table Astellas Pharma Inc. Information
Table SWOT Analysis of Astellas Pharma Inc.
Table 2019-2024 Astellas Pharma Inc. Relapsed Acute Myeloid Leukemia Drug Sale Volume Price Cost Revenue
Figure 2019-2024 Astellas Pharma Inc. Relapsed Acute Myeloid Leukemia Drug Sale Volume and Growth Rate
Figure 2019-2024 Astellas Pharma Inc. Relapsed Acute Myeloid Leukemia Drug Market Share
Table Astex Pharmaceuticals Inc. Information
Table SWOT Analysis of Astex Pharmaceuticals Inc.
Table 2019-2024 Astex Pharmaceuticals Inc. Relapsed Acute Myeloid Leukemia Drug Sale Volume Price Cost Revenue
Figure 2019-2024 Astex Pharmaceuticals Inc. Relapsed Acute Myeloid Leukemia Drug Sale Volume and Growth Rate
Figure 2019-2024 Astex Pharmaceuticals Inc. Relapsed Acute Myeloid Leukemia Drug Market Share

Companies Mentioned

  • 4SC AG
  • AbbVie Inc.
  • Actinium Pharmaceuticals Inc.
  • Agios Pharmaceuticals Inc.
  • Amgen Inc.
  • Arog Pharmaceuticals Inc.
  • Array BioPharma Inc.
  • Astellas Pharma Inc.
  • Astex Pharmaceuticals Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Acute Myeloid Leukemia (AML) Therapeutics - Global Strategic Business Report - Product Image

Acute Myeloid Leukemia (AML) Therapeutics - Global Strategic Business Report

  • Report
  • 356 Pages
  • Global
From
Acute Myeloid Leukemia Therapeutics Market by Disease Type, Treatment Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Acute Myeloid Leukemia Therapeutics Market by Disease Type, Treatment Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Acute Myeloid Leukemia Therapeutics Market Report by Treatment Type, Drug Type, Route of Administration, and Region 2024-2032 - Product Image

Acute Myeloid Leukemia Therapeutics Market Report by Treatment Type, Drug Type, Route of Administration, and Region 2024-2032

  • Report
  • 141 Pages
  • Global
From
Relapsed/refractory acute myeloid leukemia (AML) - Pipeline Insight, 2024 - Product Image

Relapsed/refractory acute myeloid leukemia (AML) - Pipeline Insight, 2024

  • Clinical Trials
  • 180 Pages
  • Global
From
Relapsed/Refractory Acute Myeloid Leukemia - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Relapsed/Refractory Acute Myeloid Leukemia - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.